Loading...
 
Mediterr J Rheumatol 2022;33(3):322-7
Assessment of Serum Resistin and Plasma Calprotectin Levels as Biomarkers of Inflammation in Patients with Familial Mediterranean Fever Disease
Authors Information

1Department of Hematology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Turkey

2Department of Gastroenterology, SBÜ Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Istanbul, Turkey

3Department of Medical Oncology, BAU Medicine School Göztepe Medical Park Hospital, Istanbul, Turkey

4Department of Internal Medicine, Sultan 2 Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

5Department of Internal Medicine, Anadolu Medical Center, Kocaeli, Turkey

6Department of Internal Medicine, Florence NightingaleHospital, Istanbul, Turkey

References
  1. Tufan A, Lachmann HJ. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci 2020;50(SI-2):1591-610.
  2. Alghamdi M. Familial Mediterranean fever, review of the literature. Clinical Rheumatology 2017;36(8):1707‐13.
  3. Özen S, Batu ED, Demir S. Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management. Frontiers in Immunology 2017;8:253.
  4. Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Presse Medicale (Paris, France: 1983) 2019;48(1 Pt 2):e61‐e76.
  5. Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO). Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 2019 Aug;78(8):1025-32.
  6. Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G, et al. Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis 2020;79(7):960-8.
  7. Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Koné-Paut I, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis 2012;71(7):1177-82.
  8. Gok M, Sirkeci O, Kara M, Sakin YS, Tanoglu A, Sirkeci EE, et al. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods. Bratislavske Lekarske Listy 2018;119(8):490-3.
  9. Erer B, Demirkaya E, Ozen S, Kallinich T. What is the best acute phase reactant for familial Mediterranean fever follow-up and its role in the prediction of complications? A systematic review. Rheumatol Int 2016;36(4):483-7.
  10. Krainer J, Siebenhandl S, Weinhäusel A. Systemic autoinflammatory diseases. J Autoimmun 2020;109:102421.
  11. Chae JJ, Aksentijevich I, Kastner DL. Advances in The Understanding Of Familial Mediterranean Fever And Possibilities For Targeted Therapy. Br J Haematol 2009;146(5):467-78.
  12. Tripathi D, Kant S, Pandey S, Ehtesham NZ. Resistin in metabolism, inflammation, and disease. FEBS J 2020;287(15):3141-9.
  13. Zhou L, Li JY, He PP, Yu XH, Tang CK. Resistin: Potential biomarker and therapeutic target in atherosclerosis. Clin Chim Acta 2021;512:84-91.
  14. Huang Q, Tao SS, Zhang YJ, Zhang C, Li LJ, Zhao W, et al. Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a metaanalysis. Clin Rheumatol 2015;34:1713-20.
  15. Kisacik B, Erol MF, Yilmaz G, Yilmaz FM, Maras Y, Kalyoncu U, et al. Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acute appendicitis? Clin Rheumatol 2012;31(2):225-9.
  16. Asan G, Derin ME, Doğan HO, Bayram M, Şahin M, Şahin A. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? J Korean Med Sci 2020 Mar 16;35(10):e63.
  17. Gucenmez OA, Kume T, Makay B, Babayigit O, Arslan N, Unsal E. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever. Int J Rheum Dis 2018;21(10):1844-8.
  18. Demirbaş F, Çaltepe G, Comba A, Abbasguliyev H, Uyar NY, Kalaycı AG. Fecal calprotectin in children with familial Mediterranean fever in the attack-free period. Pediatr Int 2019;61(11):1140-5.
  19. kendros P, Papagoras C, Mitroulis I, Ritis K. Autoinflammation: Lessons from the study of familial Mediterranean fever. J Autoimmun 2019;104:102305.
  20. Apostolidou E, Skendros P, Kambas K, Mitroulis I, Konstantinidis T, Chrysanthopoulou A, et al. Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever. Ann Rheum Dis 2016;75(1):269-77.
  21. Skendros P, Chrysanthopoulou A, Rousset F, Kambas K, Arampatzioglou A, Mitsios A, et al. Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps. J Allergy Clin Immunol 2017;140(5):1378-87.
  22. Babaoglu H, Armagan B, Bodakci E, Satis H, Atas N, Sari A, et al. Predictors of persistent inflammation in familial Mediterranean fever and association with damage. Rheumatology (Oxford) 2021;60(1):333-9.
  23. Çakan M, Aktay Ayaz N, Keskindemirci G, Karadağ ŞG, Tanatar A, Sönmez HE. Serum amyloid A as a biomarker in differentiating attacks of familial Mediterranean fever from acute febrile infections. Clin Rheumatol 2020;39(1):249-53.
  24. Yel S, Dursun I, Çetin F, Baştuğ F, Tülpar S, Düşünsel R, et al. Increased circulating endothelial microparticles in children with FMF. Biomarkers 2018;23(6):558-62.
  25. Akyol T, Düzenli T, Tanoğlu A. Evaluation of serum CXC chemokine ligand 16 (CXCL16) as a novel inflammatory biomarker for Familial Mediterranean Fever disease. Turk J Med Sci 2021;51(2):813-18.
  26. Doğan HO, Omma A, Turhan T, Boğdaycıoğlu N, Karaaslan Y, Yavuz H, et al. Decreased Chitotriosidase Activity and Levels in Familial Mediterranean Fever. J Korean Med Sci 2016;31(12):1902-6.
  27. Taylan A, Gurler O, Toprak B, Sisman AR, Yalcin H, Colak A, et al. S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever. J Korean Med Sci 2015;30(9):1241-5.
  28. Can Sandikci S, Omma A, Yucel C, Omma T. Is there a relationship between serum omentin level and acute phase response in patients with familial Mediterranean fever? Clin Rheumatol 2021;40(2):669-74.